| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UNI - EN REPORT No | 143 | / | 2013 | ||||||||
| Date of issue: | 2013-11-14 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| NOTIFICATION | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach os?b maj?cych dost?p do informacji poufnych | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (the ?Company") announces that on 13 November 2013 the Company bought 1 000 shares from the capital of Hidroizpmat AD. After this transaction, the share of Sopharma AD in the capital of Hidroizpmat AD increased to 10.02%. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 143 Hidroizomat above 10%.doc | Current report 143 Hidroizomat above 10% |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
| | | SOPHARMA AD | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | (fullname of the issuer) | | | | | |
| | | SOPHARMA AD | | Farmaceutyczny (far) | | | |
| | | (short name of the issuer) | | (sector according to clasification of the WSE in Warsow) | | | |
| | | 1220 | | Sofia | | | |
| | | (post code) | | (city) | | | |
| | | IlienskoShosse | | 16 | | | |
| | | (street) | | (number) | | | |
| | | +359 2 813 42 00 | | +359 2 936 02 86 | | | |
| | | (phone number) | | | (fax) | | |
| | | (e-mail) | | | (web site) | | |
| | | nd | | | | | |
| | | (NIP)
| | | (REGON) | | |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
|---|---|---|---|---|---|
| Date | Name | Position / Function | Signature | ||
| 2013-11-14 | Ognian Donev | Executive Director |
REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
